Inhibition of monocyte adhesion on brain-derived endothelial cells by NF-kappaB decoy/polyethylenimine complexes

Journal of Gene Medicine

Volumn 7, Issue 8, 2005, Pages 1063-1076

  Fischer, Dagmar ^a,b   Bhattacharya, Raktima ^a   Osburg, Berit ^a   Bickel, Ulrich ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Endothelium; Monocyte adhesion; NF kappaB; Polyethylenimine; Transcription factor decoy

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; NUCLEASE; POLYETHYLENEIMINE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL LABELING; CELL STRAIN U937; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DISSOCIATION; DRUG EFFICACY; DRUG SPECIFICITY; DRUG STABILITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE INHIBITION; MOLECULAR WEIGHT; MONOCYTE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALS; BRAIN; CELL ADHESION; CELL ADHESION MOLECULES; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; MICE; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES; POLYETHYLENEIMINE; U937 CELLS;

MURINAE;

EID: 23944442423     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.747     Document Type: Article

References (43)

1. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res 2000; 87: 153-159.
2. Gveric D, Kaltschmidt C, Cuzner ML, et al. Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. J Neuropathol Exp Neurol 1998; 57: 168-178.
3. Sasseville V, Newman W, Lackner A, et al. VCAM-1 is induced and mediates monocyte adhesion to endothelium in SIV encephalitis. Symp Nonhum Primate Models AIDS 1992; 10: 6.
4. Krull M, Klucken AC, Wuppermann FN, et al. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999; 162: 4834-4841.
5. Khan BV, Parthasarathy SS, Alexander RW, et al. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 1995; 95: 1262-1270.
6. Marui N, Offermann MK, Swerlick R, et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 1993; 92: 1866-1874.
7. Weber C, Erl W, Pietsch A, et al. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 1995; 91: 1914-1917.
8. Kalogeris TJ, Kevil CG, Laroux FS, et al. Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Physiol 1999; 276: L9-L19.
9. Gosh S, May MJ, Kopp EB. NF-kappaB and Rel proteins: evolutionarily conserved mediators of immune response. Annu Rev Immunol 1998; 16: 225-260.
10. Baeuerle PA, Baichwal VR. NF-kappaB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997; 65: 111-137.
11. Beg AA, Baldwin AS Jr. The IkB proteins: multifunctional regulators of Rel/NF-kappaB transcription factors. Genes Dev 1993; 7: 2064-2070.
12. Morishita R, Higaki J, Tomita N, et al. Application of transcription factor 'decoy' strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 1998; 82: 1023-1028.
13. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest 2000; 106: 1071-1075.
14. Sawa Y, Morishita R, Suzuki K, et al. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NF-kappaB binding site. Circulation 1997; 96: II280-285.
15. Vos ICH, Govers R, Gröne HJ, et al. NF-kappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2000; 14: 815-822.
16. Suzuki J, Morishita R, Amano J, et al. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Gene Ther 2000; 7: 1847-1852.
17. Zhu X, Lu L, Currier BL, et al. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles. Biomaterials 2002; 23: 2683-2692.
18. Gill JS, Zhu X, Moore MJ, et al. Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line. Biomaterials 2002; 23: 2773-2781.
19. Shibuya T, Takei Y, Hirose M, et al. A double-strand decoy DNA oligomer for NF-kappaB inhibits TNFalpha-induced ICAM-1 expression in sinusoidal endothelial cells. Biochem Biophys Res Commun 2002; 298: 10-16.
20. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci 1995; 92: 7297-7301.
21. Behr JP. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 1997; 51: 34-36.
22. Ogris M, Steinlein P, Carotta S, et al. DNA/polyethylenimine transfection particles: influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS Pharm Sci 2001; 3: E21-E32.
23. Fischer D, Bieber T, Li YX, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999; 16: 1273-1279.
24. Kunath K, von Harpe A, Fischer D, et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J Control Rel 2003; 89: 113-125.
25. von Harpe A, Petersen H, Li YX, et al. Characterization of commercially available and synthesized polyethylenimines for gene therapy. J Control Rel 2000; 69: 309-322.
26. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894-899.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
28. Osburg B. Drug delivery of oligonucleotides at the blood-brain barrier: a therapeutic strategy for inflammatory diseases of the central nervous system. PhD thesis, University of Marburg, Germany, 2003; Available: http://archiv.ub.uni-marburg.de/opus/frontdoor.php?source_opus=445.
29. Ogris M, Steinlein P, Kursa M, et al. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425-1433.
30. Aigner A, Fischer D, Merdan T, et al. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression. Gene Ther 2002; 9: 1700-1707.
31. Fischer D, von Harpe A, Kunath K, et al. Copolymers of ethyleneimine and N-(2-hydroxyethyl)ethyleneimine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. Bioconjugate Chem 2002; 13: 1124-1133.
32. Reiss Y, Engelhardt B. T cell interaction with ICAM-1-deficient endothelium in vitro: transendothelial migration of different T cell populations is mediated by endothelial ICAM-1 and ICAM-2. Int Immunol 1999; 11: 1527-1539.
33. Laschinger M, Engelhardt B. Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cells blasts to brain endothelium but not in their transendothelial migration in vitro. J Neuroimmunol 2000; 102: 32-43.
34. Chan H, Aggarwal BB. Role of tumor necrosis factor receptors in the activation of nuclear factor kappa B in human histiocytic lymphoma U-937 cells. J Biol Chem 1994; 269: 31 424-31 429.
35. Legrand-Poels S, Maniglia S, Boelaert JR, et al. Activation of the transcription factor NF-kappaB in lipopolysaccharide-stimulated U937 cells. Biochem Pharmacol 1997; 53: 339-346.
36. Ahlemeyer B, Fischer D, Kissel T, et al. Staurosporine-induced apoptosis in cultured chick embryonic neurons is reduced by polyethylenimine of low molecular weight used as a coating substrate. Neurosci Res 2000; 37: 245-253.
37. Fischer D, Li YX, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121-1131.
38. Graulich W, Nettelbeck DM, Fischer D, et al. Cell type specificity of the human endoglin promotor. Gene 1999; 227: 55-62.
39. Choksakulnimitr S, Masuda S, Tokuda H, et al. In vitro cytotoxicity of macromolecules in different cell culture systems. J Control Rel 1995; 34: 233-241.
40. Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1997; 1329: 345-356.
41. Mahato RI, Furgeson DY., Maheshwari A, et al. Polymeric delivery for cancer treatment. In Biomaterials and Drug Delivery Toward the New Millenium. Park KD, Kwon IC, Yui N, et al. (eds). Han Rim Wan Publishing Co.: Seoul, Korea, 2000.
42. Merdan T, Kunath K, Fischer D, et al. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res 2002; 19: 140-146.
43. Lee HJ, Engelhardt B, Lesley J, et al. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. J Pharmacol Exp Ther 2000; 292: 1048-1052.